What Is Quality by Design and Why It Matters in PharmaUntitledA Science-Based Route to Consistent Quality
Quality by Design (QbD) is a systematic, science-based approach to pharmaceutical and biopharmaceutical development that builds quality into a product from the design stage rather than testing it in at the end. This Quality by Design Training in Taiwan gives formulation, analytical, process development and regulatory professionals the practical tools to apply QbD in everyday development work. The programme is grounded in the ICH framework that regulators now expect: ICH Q8(R2) Pharmaceutical Development, ICH Q9 Quality Risk Management, ICH Q10 Pharmaceutical Quality System and ICH Q11 for drug substances. You learn to define the Quality Target Product Profile (QTPP), identify Critical Quality Attributes (CQAs), run structured risk assessments, explore the design space through Design of Experiments (DoE), and build a robust control strategy supported by Process Analytical Technology. Taiwan's biopharma sector is expanding fast, and its many FDA and EMA approved sites, CDMOs and biosimilar developers must meet TFDA, FDA and EMA expectations. QbD is the capability that turns strong science into consistent, submission-ready products. Delivered in live virtual, classroom and corporate formats, this is a one-day, non-certification skills programme focused on hands-on application, so you can start using QbD tools straight away.










